Skip to content

Efficacy and safety of transcutaneous electrical acupoint stimulation (TEAS) combined with patient-controlled epidural analgesia (PCEA) for labour analgesia

Efficacy and safety of transcutaneous electrical acupoint stimulation (TEAS) combined with patient-controlled epidural analgesia (PCEA) for labour analgesia - TEAS combined with PCEA for labour analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050983
Enrollment
70
Registered
2023-05-05
Start date
2023-05-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Participants were in the active phase of labour at the time. The inclusion criteria were as follows: the fetus must have reached a gestational age of 37 to 42 weeks

Interventions

Puerperants were placed in the left-lateral position. The puncture point was between L 3 and L 4. After confirming the puncture was correct, a 4 cm epidural catheter was inserted into the cephalic sid

Sponsors

Department of Anaesthesiology, People's Hospital of Chongqing Banan District
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Recruited for this study were nulliparous parturients with healthy singleton pregnancies, gestational age >37 weeks, American Society of Anesthesiologists Physical Status II spontaneous onset of labor, no previous poor obstetrical outcome, no experience of pain relief by systemic or epidural anesthesia in a previous delivery, no experience in acupuncture or TEAS for other reasons,active phase of labor with cervical dilation of 3 cm, and painful contractions requiring labor epidural analgesia.

Exclusion criteria

Exclusion criteria: Patients were excluded if they: (1) had the history of experimental drug allergy; (2) had been diagnosed with other diseases such as preoperative presence of maternal mental, neurological diseases, affecting evaluation of pains and disease conditions; (3) had combined with gestational hypertension, gestational diabetes, gestational thyroid diseases; (4) had taken analgesic drugs or with a history of long-term use of analgesic drugs; (5) had used diazepam, piperazine hydrochloride or other sedative, analgesic drugs in the stages of labor; (6 ) were overweight or low pregnancy weight,body mass index < 18.5 or > 25; (7) were not agree to receive painless labor and not sign the informed consent from; (8) fetal compromise; (9) maternal cutaneous lesions on the application sites such as wound scars, urticaria or insect bites; (10) candidates for vaginal birth after cesarean section; and (11) pacemaker users; (12) absolute contraindications or relative contraindications to spinal anesthesia.

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study was the total volume of anesthetic solution consumed in the PCEA device.

Countries

Asia(except Japan)

Contacts

Public Contactjie Chen

People's Hospital of Chongqing Banan District Department of Anaesthesiology

cjandsh@tmmu.edu.cn+81-086-23-66234145

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026